title: Pharmacological manipulation of glucocorticoid receptors differentially affects cocaine self-administration in environmentally enriched and isolated rats.
abstract: Social isolation rearing (isolated condition, IC) is used as a model of early life stress in rodents. Rats raised in this condition are often compared to rats raised in an environmentally enriched condition (EC). However, EC rats are repeatedly exposed to forced novelty, another classic stressor in rodents. These studies explored the relationship between cocaine self-administration and glucocorticoid receptor (GR) activation and measured total levels of GR protein in reward-related brain regions (medial prefrontal cortex, orbitofrontal cortex, nucleus accumbens, amygdala) in rats chronically exposed to these conditions. For Experiment 1, rats were housed in EC or IC and were then trained to self-administer cocaine. Rats raised in these housing conditions were tested for their cocaine responding after pretreatment with the GR antagonist, RU486, or the GR agonist, corticosterone (CORT). For Experiment 2, levels of GR from EC and IC rats were measured in brain regions implicated in drug abuse using Western blot analysis. Pretreatment with RU486 (20mg/kg) decreased responding for a low unit dose of cocaine (0.03 mg/kg/infusion) in EC rats only. IC rats were unaffected by RU486 pretreatment, but earned significantly more cocaine than EC rats after pretreatment with CORT (10mg/kg). No difference in GR expression was found between EC and IC rats in any brain area examined. These results, along with previous literature, suggest that enrichment enhances responsivity of the HPA axis related to cocaine reinforcement, but this effect is unlikely due simply to differential baseline GR expression in areas implicated in drug abuse.
authors: Department of Psychology, University of Kentucky, Lexington, KY, USA. Electronic address: rebecca.hofford@uky.edu.
authors: Rebecca S
authors: RS
authors: Hofford
authors: Department of Psychology, University of Kentucky, Lexington, KY, USA.
authors: Mark A
authors: MA
authors: Prendergast
authors: Department of Psychology, University of Kentucky, Lexington, KY, USA; Center for Drug Abuse Research Translation, University of Kentucky, Lexington, KY, USA.
authors: Michael T
authors: MT
authors: Bardo
mesh_terms: D000818:Animals; D003042:Cocaine / Q000008:administration & dosage*; D019970:Cocaine-Related Disorders / Q000188:drug therapy / Q000378:metabolism; D003345:Corticosterone / Q000494:pharmacology; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage*; D006727:Hormone Antagonists / Q000494:pharmacology; D006799:Housing, Animal; D008297:Male; D015735:Mifepristone / Q000494:pharmacology; D011897:Random Allocation; D017207:Rats, Sprague-Dawley; D011965:Receptors, Glucocorticoid / Q000819:agonists* / Q000037:antagonists & inhibitors* / Q000378:metabolism; D012646:Self Administration; D012934:Social Isolation
chemical_list: D018765:Dopamine Uptake Inhibitors; D006727:Hormone Antagonists; D011965:Receptors, Glucocorticoid; D015735:Mifepristone; D003042:Cocaine; D003345:Corticosterone
keywords: Cocaine self-administration; Corticosterone; Environmental enrichment; Glucocorticoid receptor; RU486; Social isolation
references: Neuroscience. 2010 Aug 11;169(1):214-22
references: 20438813
references: Cell Cycle. 2012 Aug 1;11(15):2819-27
references: 22801547
references: Endocrinology. 1998 Feb;139(2):579-87
references: 9449628
references: Psychopharmacology (Berl). 2014 Apr;231(8):1557-80
references: 24370534
references: Behav Pharmacol. 2012 Oct;23(7):650-7
references: 22914073
references: Eur J Pharmacol. 2013 Mar 5;703(1-3):62-6
references: 23422875
references: J Neuroendocrinol. 2004 May;16(5):423-31
references: 15117335
references: Neurobiol Learn Mem. 2014 Jul;112:212-21
references: 24508065
references: Brain Res Mol Brain Res. 1994 Jun;23(4):349-53
references: 8090075
references: Addict Biol. 2010 Jan;15(1):81-7
references: 19799583
references: J Pharmacol Exp Ther. 1997 Jun;281(3):1401-7
references: 9190876
references: Brain Res. 2010 Feb 16;1314:235-52
references: 19914222
references: Physiol Behav. 2014 Apr 22;129:118-29
references: 24582669
references: J Neurosci. 2013 Jul 17;33(29):11800-10
references: 23864669
references: Neuroendocrinology. 2007;85(3):186-92
references: 17446698
references: Neuropsychopharmacology. 2009 Nov;34(12):2609-17
references: 19675537
references: Prog Neurobiol. 2010 Dec;92(4):572-92
references: 20713127
references: Psychopharmacology (Berl). 2001 May;155(3):278-84
references: 11432690
references: Drug Alcohol Depend. 1998 Dec 1;53(1):67-77
references: 10933341
references: J Neurotrauma. 2007 Nov;24(11):1761-72
references: 18001204
references: Neuropsychobiology. 2009;59(4):213-21
references: 19521113
references: Front Neurol. 2014 Apr 09;5:44
references: 24782818
references: Endocrinology. 1964 Feb;74:279-83
references: 14122535
references: Brain Res. 1996 May 25;722(1-2):145-52
references: 8813360
references: Brain Res. 1995 Nov 6;698(1-2):46-52
references: 8581502
references: Neuropharmacology. 2000 Jan 4;39(2):334-46
references: 10670429
references: J Neural Transm (Vienna). 2013 May;120(5):829-43
references: 23254925
references: Ethn Dis. 2010 Winter;20(1 Suppl 1):S1-73-7
references: 20521389
references: Psychopharmacology (Berl). 1994 Feb;114(1):63-70
references: 7846208
references: Psychopharmacology (Berl). 2014 Sep;231(18):3787-98
references: 24595506
references: Physiol Behav. 2011 Feb 1;102(2):225-33
references: 21092743
references: Neuropsychopharmacology. 2011 Mar;36(4):848-56
references: 21150905
references: Contraception. 2003 Dec;68(6):409-20
references: 14698070
references: J Am Acad Child Adolesc Psychiatry. 1997 Dec;36(12):1744-51
references: 9401336
references: Neuroscience. 2000;100(4):749-68
references: 11036209
references: Acta Histochem. 2010 Mar;112(2):147-60
references: 19100597
references: J Neurosci. 2003 Jun 1;23(11):4785-90
references: 12805318
references: Psychopharmacology (Berl). 2011 Nov;218(1):293-301
references: 21887496
references: Subst Abuse. 2013 Oct 13;7:171-83
references: 24151426
references: Physiol Behav. 2011 Jun 1;103(3-4):412-20
references: 21406199
references: Subst Use Misuse. 2010 Oct;45(12):1948-70
references: 20380553
references: Brain Res. 2010 Nov 4;1359:75-80
references: 20813098
references: Neuropsychopharmacology. 2004 May;29(5):929-42
references: 14735136
references: Behav Brain Res. 2011 Jan 1;216(1):349-57
references: 20732356
references: Behav Brain Res. 1991 Apr 18;43(1):35-50
references: 1677579
references: Neuroendocrinology. 1996 Nov;64(5):337-48
references: 8930934
references: Behav Pharmacol. 2009 Jul;20(4):312-21
references: 19584714
references: Endocrinology. 1997 Aug;138(8):3476-85
references: 9231802
references: J Pharmacol Exp Ther. 1998 Oct;287(1):72-80
references: 9765324
references: Neuroscience. 2002;113(2):395-400
references: 12127096
references: Biochem Pharmacol. 2012 Jan 1;83(1):1-5
references: 21843515
references: Psychoneuroendocrinology. 2002 Jan-Feb;27(1-2):13-33
references: 11750768
references: Brain Behav Immun. 2008 Jan;22(1):105-13
references: 17890050
references: Am J Community Psychol. 1992 Jun;20(3):349-74
references: 1415032
references: Biol Psychiatry. 2010 Jan 1;67(1):28-35
references: 19709647
references: Front Integr Neurosci. 2014 Jan 02;7:102
references: 24427122
references: Brain Res. 2014 Aug 5;1575:45-54
references: 24887642
references: Behav Brain Res. 2007 Mar 28;178(2):274-82
references: 17254644